StockData

NuCana plc (NCNA) income statement

NCNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 19, 2026Score 1/30
$0.89+0.03 (+3.49%)

Close on Nov 17, 2026Market cap $3.70MP/E –Yield –

NuCana plc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
–

Financial strength

Current ratio
4.73
Debt to equity
–
Debt to assets
–
Cash to current liabilities
404.0%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?